HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Successful renal contraction therapy in polycystic kidney patient with renal transcatheter arterial embolization prior to ABO incompatible kidney transplantation].

Abstract
28-year-old female received dialysis treatment due to chronic renal failure caused by polycystic kidney disease. Later, she underwent a laparoscopic splenectomy and ABO incompatible living kidney transplantation successfully following bilateral renal contraction therapy with renal transcatheter arterial embolization (renal TAE). A unilateral or bilateral native nephrectomy of a massively enlarged kidney performed at the time of renal transplantation is a common treatment in polycystic kidney patients scheduled for transplantation. On the other hand, when treated with renal TAE, such patients can avoid a laparotomy, which provides several advantages when undergoing peritoneal dialysis in the future or a laparoscopic splenectomy prior to ABO incompatible kidney transplantation. Furthermore, we consider that bilateral renal TAE is necessary for polycystic kidney patients prior to renal transplantation for a variety of reasons, including problems associated with contrast nephropathy if renal TAE for left kidney is remained after renal transplantation.
AuthorsTaigo Kato, Koji Yazawa, Naotsugu Ichimaru, Jun Saito, Koichi Tsutahar, Yoichi Kakuta, Toyofumi Abe, Yasutomo Nakai, Norio Nonomura, Shiro Takahara, Akihiko Okuyama
JournalNihon Hinyokika Gakkai zasshi. The japanese journal of urology (Nihon Hinyokika Gakkai Zasshi) Vol. 101 Issue 6 Pg. 730-3 (Sep 2010) ISSN: 0021-5287 [Print] Japan
PMID20954380 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • ABO Blood-Group System
Topics
  • ABO Blood-Group System
  • Adult
  • Blood Group Incompatibility
  • Embolization, Therapeutic (methods)
  • Female
  • Humans
  • Kidney (pathology)
  • Kidney Transplantation
  • Polycystic Kidney Diseases (pathology, therapy)
  • Renal Artery
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: